Gene Therapy (journal)
| Discipline | Gene therapy, Molecular medicine, Genetics |
|---|---|
| Language | English |
| Edited by | Janine Scholefield |
| Publication details | |
| History | Since 1994 |
| Publisher | |
| Frequency | Bimonthly |
| Hybrid | |
| 4.5 (2024) | |
| Standard abbreviations | |
| ISO 4 | Gene Ther. |
| Indexing | |
| CODEN | GETHEC |
| ISSN | 0969-7128 (print) 1476-5462 (web) |
| LCCN | sn94038215 |
| OCLC no. | 224625632 |
| Links | |
Gene Therapy is a bimonthly[1] peer-reviewed scientific journal covering research and clinical applications of gene therapy. It is published by Springer Nature and the editor-in-chief is Janine Scholefield (Council for Scientific and Industrial Research).[2]
The journal publishes research articles, reviews, brief communications, perspectives, and editorials spanning gene delivery vectors, genome editing, cell-based therapies, preclinical models, clinical trials, and translational and regulatory topics.[3]
Abstracting and indexing
The journal is abstracted and indexed in:[4]
According to the Journal Citation Reports, the journal has a 2024 impact factor of 4.5.[8]
References
- ^ "Subscribe to Gene Therapy". Gene Therapy. Springer Nature. Retrieved 2025-12-22.
- ^ "About the Editors". Gene Therapy. Springer Nature. Retrieved 2025-12-22.
- ^ "Guide to Authors" (PDF). Gene Therapy. Springer Nature. Retrieved 2025-12-22.
- ^ "Gene Therapy". MIAR: Information Matrix for the Analysis of Journals. University of Barcelona. Retrieved 2025-12-22.
- ^ a b c d "Gene Therapy". Web of Science Master Journal List. Clarivate. Retrieved 2025-12-22.
- ^ "Gene Therapy". NLM Catalog. National Center for Biotechnology Information. Retrieved 2025-12-22.
- ^ "Source details: Gene Therapy". Scopus Preview. Elsevier. Retrieved 2025-12-22.
- ^ "Gene Therapy". 2024 Journal Citation Reports (Science ed.). Clarivate. 2025 – via Web of Science.